01 1Amphastar Nanjing Pharmaceuticals, Inc.
01 1Hyaluronidase
01 1U.S.A
NDC Package Code : 52221-201
Start Marketing Date : 2015-06-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
35
PharmaCompass offers a list of Hyaluronidase API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hyaluronidase manufacturer or Hyaluronidase supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hyaluronidase manufacturer or Hyaluronidase supplier.
PharmaCompass also assists you with knowing the Hyaluronidase API Price utilized in the formulation of products. Hyaluronidase API Price is not always fixed or binding as the Hyaluronidase Price is obtained through a variety of data sources. The Hyaluronidase Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HYLENEX RECOMBINANT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HYLENEX RECOMBINANT, including repackagers and relabelers. The FDA regulates HYLENEX RECOMBINANT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HYLENEX RECOMBINANT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of HYLENEX RECOMBINANT manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A HYLENEX RECOMBINANT supplier is an individual or a company that provides HYLENEX RECOMBINANT active pharmaceutical ingredient (API) or HYLENEX RECOMBINANT finished formulations upon request. The HYLENEX RECOMBINANT suppliers may include HYLENEX RECOMBINANT API manufacturers, exporters, distributors and traders.
click here to find a list of HYLENEX RECOMBINANT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing HYLENEX RECOMBINANT as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for HYLENEX RECOMBINANT API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture HYLENEX RECOMBINANT as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain HYLENEX RECOMBINANT and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a HYLENEX RECOMBINANT NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of HYLENEX RECOMBINANT suppliers with NDC on PharmaCompass.
We have 1 companies offering HYLENEX RECOMBINANT
Get in contact with the supplier of your choice:
